using ibrutinib in chronic lymphocytic leukemia (cll)
Published 8 years ago • 4.2K plays • Length 7:13Download video MP4
Download video MP3
Similar videos
-
11:28
adverse events of ibrutinib in chronic lymphocytic leukemia
-
5:55
pharmacovigilance with ibrutinib in chronic lymphocytic leukemia
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
4:22
progression on frontline ibrutinib in cll
-
9:02
efficacy and future role of ibrutinib in cll and mcl
-
7:17
the use of ibrutinib in cll
-
4:07
management of cll progression after ibrutinib
-
2:15
dr. kay discusses the role of ibrutinib in cll
-
1:16
dr. jones on long-term outcomes with ibrutinib in cll
-
1:41
dr. jacobs on the use of ibrutinib in high-risk patients with cll
-
8:26
small-molecule inhibitors: ibrutinib in chronic lymphocytic leukemia
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
2:04
dr. chavez on ongoing efficacy and challenges with ibrutinib in cll
-
7:01
novel frontline combinations with ibrutinib in cll
-
1:35
dr. awan discusses combinations with ibrutinib in cll
-
6:32
ibrutinib therapy in chronic lymphocytic leukemia
-
0:51
dr. seymour on role of ibrutinib in cll
-
1:00
dr. smith on ibrutinib-based therapies in cll